Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Omega Therapeutics stock

Learn how to easily invest in Omega Therapeutics stock.

Omega Therapeutics is a biotechnology business based in the US. Omega Therapeutics shares (OMGA) are listed on the NASDAQ and all prices are listed in US Dollars. Omega Therapeutics employs 79 staff and has a trailing 12-month revenue of around $1.5 million.

How to buy Omega Therapeutics stock

  1. Open a stock trading account. Use our comparison table or choose from our Top Picks.
  2. Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
  3. Search for the stock by name or ticker symbol – OMGA. It's that simple.

Best for low fees

Finder Award

SoFi Invest


  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Promoted for easy user experience

Robinhood


  • Commission-free trading
  • Commission-free crypto
  • No minimum account balance

Promoted

tastyworks


  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.

Omega Therapeutics stock price (NASDAQ: OMGA)

Use our graph to track the performance of OMGA stocks over time.

Omega Therapeutics shares at a glance

Information last updated 2023-01-19.
Latest market close$7.75
52-week range$1.98 - $14.31
50-day moving average $6.37
200-day moving average $4.97
Wall St. target price$15.00
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-2.26

Buy Omega Therapeutics stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Public.com
Stocks, ETFs, Cryptocurrency, Alternatives
$0
$0
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
$0
$0
N/A
Winner of Finder’s Best Overall Stock Broker award.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy Omega Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Omega Therapeutics price performance over time

Historical closes compared with the close of $7.75 from 2023-01-25

1 week (2023-01-19) 12.48%
1 month (2022-12-27) 63.16%
3 months (2022-10-27) 47.06%
6 months (2022-07-27) 40.65%
1 year (2022-01-27) -28.17%
2 years (2021-01-23) N/A
3 years (2020-01-23) N/A
5 years (2018-01-23) N/A

Omega Therapeutics financials

Revenue TTM $1.5 million
Gross profit TTM $-47,721,000
Return on assets TTM -27.96%
Return on equity TTM -52.39%
Profit margin 0%
Book value $2.79
Market capitalisation $331.1 million

TTM: trailing 12 months

Omega Therapeutics share dividends

We're not expecting Omega Therapeutics to pay a dividend over the next 12 months.

Omega Therapeutics overview

Omega Therapeutics, Inc. operates as a clinical-stage biotechnology company. Its OMEGA Epigenomic Programming platform harnesses the power of epigenetics, as well as the mechanism that controls gene expression and aspect of an organism's life. The company's platform enables control of fundamental epigenetic processes to correct the root cause of disease by returning aberrant gene expression to a range without altering native nucleic acid sequences. Its modular and programmable mRNA medicines, and Omega Epigenomic Controllers are designed to target specific epigenomic loci within insulated genomic domains from genome-wide DNA-sequences with single or multiple genes to treat and cure diseases through Precision Genomic Control. The company is advancing a pipeline of development candidates covering a range of disease areas, including oncology, regenerative medicine, multigenic diseases, and select monogenic diseases. The company was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.

Frequently asked questions

What percentage of Omega Therapeutics is owned by insiders or institutions?
Currently 3.69% of Omega Therapeutics shares are held by insiders and 88.787% by institutions.
How many people work for Omega Therapeutics?
Latest data suggests 79 work at Omega Therapeutics.
When does the fiscal year end for Omega Therapeutics?
Omega Therapeutics's fiscal year ends in December.
Where is Omega Therapeutics based?
Omega Therapeutics's address is: 20 Acorn Park Drive, Cambridge, MA, United States, 02140
What is Omega Therapeutics's ISIN number?
Omega Therapeutics's international securities identification number is: US68217N1054

More guides on Finder

Ask an Expert

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site